Streetbeat News

Price Targets

CRWD

Mizuho analyst Gregg Moskowitz has maintained a Buy rating on CrowdStrike Holdings (NASDAQ:CRWD) and increased the price target from $205 to $225. This adjustment reflects a positive outlook on the company's stock, suggesting potential upside from the current trading levels.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 5:12 pm

COIN

Mizuho analyst Dan Dolev has maintained an Underperform rating on Coinbase Global (NASDAQ:COIN) but increased the price target from $31 to $35.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 5:09 pm

KIM

Stifel has reaffirmed its Buy rating on Kimco Realty (NYSE:KIM) and increased its price target from $20.50 to $21.75. Kimco Realty's shares have risen 0.98% in the last 24 hours to $19.16. The new price target suggests a potential upside of 13.55% from the current share price. Kimco Realty is one of the oldest REITs in the U.S., with interests in over 5,000 shopping centers.

Portfolio Pulse from Benzinga Insights

November 29, 2023 | 5:00 pm

GDDY

Benchmark has reaffirmed its Buy rating on GoDaddy (NYSE:GDDY) and increased its price target from $96.00 to $125.00. GoDaddy's stock is currently up 1.07% at $98.11, and the new price target suggests a potential upside of 27.41%. GoDaddy offers a range of services including domain registration, hosting, security, and omnicommerce solutions, targeting various small to medium-sized business sectors.

Portfolio Pulse from Benzinga Insights

November 29, 2023 | 5:00 pm

HPE

Barclays has maintained its Equal-Weight rating on Hewlett Packard (NYSE:HPE) but lowered its price target from $16.00 to $15.00. Despite this, HPE shares have risen 5.67% in the last 24 hours to $16.40. The new price target suggests a potential downside of 8.54% from the current price. Hewlett Packard Enterprise focuses on IT hardware and software for enterprises, aiming to be a comprehensive edge-to-cloud company.

Portfolio Pulse from Benzinga Insights

November 29, 2023 | 5:00 pm

FBIO

Roth MKM has maintained a Buy rating for Fortress Biotech (NASDAQ:FBIO) but reduced its price target from $30.00 to $15.00. Despite the reduction, the new target suggests a significant upside from the current trading price of $1.99, with a potential increase of 653.77%. Fortress Biotech is a biopharmaceutical company with a focus on acquiring, developing, and commercializing pharmaceutical and biotechnology products, primarily in dermatology.

Portfolio Pulse from Benzinga Insights

November 29, 2023 | 5:00 pm

CCRN

Cross Country Healthcare (NASDAQ:CCRN) received mixed analyst ratings in the last quarter with 1 bullish, 1 somewhat bullish, and 2 indifferent ratings. The average 12-month price target among 4 analysts is $25.25, with a high of $32.00 and a low of $21.00. This target is a 19.84% decrease from the previous target of $31.50. Analysts provide these ratings by researching company financials, attending calls and meetings, and speaking with insiders.

Portfolio Pulse from Benzinga Insights

November 29, 2023 | 5:00 pm

KIM

Kimco Realty (NYSE:KIM) received 5 analyst ratings in the last quarter, with 3 bullish and 2 indifferent, and no bearish ratings. The average price target is $20.75, representing an implied upside from the current price of $19.15. This target is a 4.33% decrease from the previous target of $21.69. Analysts' ratings are based on financial predictions and company performance assessments.

Portfolio Pulse from Benzinga Insights

November 29, 2023 | 5:00 pm

MU

Raymond James has reaffirmed its Outperform rating on Micron Technology (NASDAQ:MU) and increased its price target from $76.00 to $82.00. Micron's shares have risen 1.76% in the last 24 hours to $77.46. The new price target suggests a potential upside of 5.86%. Micron is a major semiconductor company, focusing on DRAM and NAND flash chips, serving various markets including data centers and mobile phones.

Portfolio Pulse from Benzinga Insights

November 29, 2023 | 5:00 pm

GTLS

Analysts have provided ratings for Chart Industries (NYSE:GTLS) with 2 bullish, 1 somewhat bullish, and 1 indifferent rating in the last quarter. The average price target is $203.5, suggesting a significant upside from the current price of $128.57. The target has increased by 3.3% over the past month.

Portfolio Pulse from Benzinga Insights

November 29, 2023 | 5:00 pm